Afleveringen
-
What is the relationship between food and metabolic health? Find out with Saira Hameed, Consultant Endocrinologist at Imperial College Healthcare NHS Trust, and a Senior Tutor and Honorary Clinical Senior Lecturer at Imperial College London. In this episode, Jonathan and Hameed discuss her book “The full Diet,” and how food intake alters energy expenditure in turn metabolic rate.
Please use the following timestamps to navigate the episode:
(00:00)-Introduction
(02:54)-The evolution of Saira’s journey
(05:49)- Imperial-SatPro weight management programme
(12:27)- The Full Diet
(20:59)- Powerful of the 200 references
(24:54)- What we eat, how we eat, and what we weigh have an impact
-
Is social media a force for good or evil? Find out in this week's podcast episode, where Jonathan and Brennan Spiegel, Director of Health Services Research at Cedars-Sinai Medical Center explore AI and social media, before discussing irritable bowel syndrome and the gastro-intestinal manifestations of COVID-19.
Use the following timestamps to navigate this week's episode:
(00:00)-Introduction
(01:02)- Social media as a force for good or evil
(07:36)-Artificial intelligence: preserving the humanity of healing
(11:48)-Gastro-intestinal manifestations of COVID-19
(14:34)-Navigating the assault course of the GI tract
(16:40)-Irritable bowel syndrome
(20:26)-The flaws of healthcare systems, how can technology help?
(24:55)-Brennan’s 3 wishes
-
Zijn er afleveringen die ontbreken?
-
Join Michelle Michels, Head of the Centre of Expertise for Inherited Cardiovascular Disease, Erasmus University Medical Centre, Rotterdam, the Netherlands, for the latest episode of the EMJ Podcast. A summary of the pathophysiology and clinical manifestations of HCM is presented, followed by a discussion on the challenges in managing HCM, the correlations between genotype and phenotype, and significant advancements derived from the analysis of long-term extension data. Listen now for more insights into this fascinating subject!
-
How can virtual reality improve patient care? Find out in this week's podcast episode, where Jonathan and Brennan Spiegel, Director of Health Services Research at Cedars-Sinai Medical Center discuss the philosophy of mind and the effects of virtual reality on the human mind.
Timestamps:
(00:00)-Introduction
(02:33)- Brennan’s spark towards the human body
(04:11)-The philosophy of mind
(05:08)-Effects of VR on human mind
(08:01)-VR at Cedars
(10:43)-Two sides of a coin
(13:36)-The future of augmented reality
(16:47)-The big picture of VR use
-
Join us for the latest EMJ Podcast episode about PBC, in which leading experts in the field discuss the newest developments and regulatory challenges in advancing treatment. David Jones, Newcastle University, UK; and Gideon Hirschfield, Toronto General Hospital, Ontario, Canada, address the impacts of treatment on patient quality of life, as well as the difficulties of collecting long-term data.
-
How can hypnosis be introduced in clinical practice? Find out with Sarah Partridge, Consultant in Clinical Oncology at Imperial Healthcare NHS Trust, London. In this second instalment, Jonathan and Sarah discuss success stories of hypnosis in a medical setting, and the potential benefits it provides to patient care.
Use the following timestamps to navigate the episode:
(00:00)-Introduction
(01:00)-Sarah’s approach to communicating hypnosis to patients
(06:22)-Success story of hypnosis
(08:12)-Clinical trials testing hypnosis in clinical practice
(16:30)-Sarah’s three magical wishesEpisode 204: Hypnosis: A Magical Tool in Clinical Scenarios – Part 2
-
Could clinical hypnosis improve outcomes for patients? Find out with Sarah Partridge, Consultant in Clinical Oncology at Imperial Healthcare NHS Trust, London. In this episode, Jonathan and Partridge discuss how hypnosis can be harnessed in a clinical setting, how it can be normalised, and its impact managing side effects.
Use the following timestamps to navigate our episode!
(00:00)-Introduction
(01:45)-Sarah’s route to clinical oncology
(04:22)-Discovering and implementing hypnosis as a tool
(08:12)-Hypnosis in managing side effects
(12:18)-Hypnosis in clinical scenarios
(16:31)-Tranceform: The era of digital resources
(21:00)-Normalising clinical hypnosis
(24:51)-Hypnosis: A different form of dissociative state
-
This podcast explores health psychology in gastroenterology. Jonathan and Megan Riehl, University of Michigan, Ann Arbor, USA, discuss brain-gut behavioural therapies, misconceptions surrounding mental health and gastrointestinal conditions, and her book "Mind Your Gut".
Timestamps:
(00:00)-Introduction
(03:28)-Megan’s journal to health psychology
(6:30)-Lifestyle factors and digestive distress
(10:45)-Brain-gut behavioural therapies
(17:00)-Common misconceptions in IBS
(21:34)-The microbiome: feeding your gut
(25:20)-Integrating GI mental health into practice
(29:45)- 'Mind Your Gut'
(35:06)-‘The Gut Health Podcast’
(38:40)-Megan’s three wishes for healthcare
-
Nick Oliver, Wynn Professor of Human Metabolism at Imperial College Healthcare NHS Trust, London, UK, joins Jonathan to discuss all things diabetes, from patient education to awareness for diabetes prevention, as well as research into islet cell transplantation.
Use the following timestamps to navigate our episode!
(00:00)-Introduction
(02:25)-Nick Oliver, playwright
(05:07)-Nick’s ‘origin story’
(07:33)-Acknowledging the current challenges in diabetes treatment, and goals for the future
(11:00)-Patient awareness and education in the treatment and management of diabetes
(15:29)-Technology in aiding diabetes treatment
(19:03)-Quality of life in real-time continuous glucose monitoring in children
(21:49)-The artificial pancreas: where is it now, and where is it going?
(26:12)-Intraocular islet cell transplantation in early-onset diabetic retinopathy
(29:54)-Innovative developments on the horizon
(33:07)-Research on increased glycaemic variability in pregnant females with gastric bypass
(35:43)-The work of the European Association for the Study of Diabetes (EASD)
(37:16)-Three wishes for the future of healthcare
-
This episode focuses on monogenic diabetes, diabetes research, and inspiring the next generation of nurses. Jonathan is joined by Maggie Shepherd, Honorary Clinical Professor at the University of Exeter Medical School, UK. The pair explore how we can strengthen the research influence of nurses, including the 70@70 programme, as well as Shepherd’s initiatives to encourage a career in nursing and research in nursing.
Use the following timestamps to navigate our episode!
(00:00)-Introduction
(03:43)-Entering into diabetes research
(04:27)-Monogenic diabetes
(07:01)-70@70 initiative
(11:00)-Aster Guardians Global Nursing award
(12.32)-Successes, challenges, and opportunities in monogenic diabetes
(14:48)-Patient care during COVID-19
(17:30)-‘1 in 6 Billion’ podcast
(19:56)-Inspiring the next generation
(23:09)-Maggie’s wishes for the future of healthcare -
CoMiSS, the “Cow’s Milk related Symptom Score”, is a valuable resource for healthcare professionals, parents, and carers alike, offering an easy-to-use awareness tool that supports the recognition of cow’s milk-related symptoms in infants and young children.
2024 marks the 10th anniversary of CoMiSS, prompting us to look back at the decade of science and clinical practice behind the tool. The podcast reflects on the tool’s inception, its impact on aiding earlier diagnosis, and its role in evaluating therapeutic interventions for managing symptoms of cow’s milk allergy (CMA).
-
This podcast episode dives into the screening and management of Duchenne muscular dystrophy, as well as diversity in genetic databases, and treating neuromuscular disorders. Jonathan is joined by Madhuri Hegde, Senior Vice-President & Chief Scientific Officer at Revvity, Inc., to talk about innovation in genomic testing.
Use the following timestamps to navigate our episode!
(00:00)-Introduction
(03:54)-Entering into genomic technologies
(05:13)-Duchenne muscular dystrophy
(10:47)-Revvity and genome sequencing
(13:13)-Ultrarapid genomic testing (urWGS)
(15:18)-LANTERN project
(17:42)-Lack of diversity in genetic databases
(20:06)-New developments in genetics
(22:19)-COVID-19 testing laboratories
(27:27)-Madhuri’s wishes for healthcare
-
Jonathan is joined by Joshua Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign, Stanford University, California, USA. The pair navigate fascinating themes, from Makower’s passion for music and his band, Still Trust, to innovative strategies for controlling rising healthcare costs through innovation. Makower offers perspectives on AI in healthcare, and the associated challenges with regulating these new technologies.
Use the following timestamps to navigate the topics discussed in this episode:
(00:00)-Introduction
(03:05)-A passion for music
(06:11)-From the Massachusetts Institute of Technology (MIT) to medical school
(08:50)-The Biodesign process
(19:37)-Driving technology from mind to marketplace
(23:25)-Doctors engaging with industry
(27:52)-The ExploraMed incubator
(31:07)-Josh’s current work
(34:27)-The importance of failure
(36:16)-Perspectives on artificial intelligence in healthcare
(39:05)-Healthcare innovation horizons
(40:37)-Medical technology regulation
(46:00)-Josh’s three wishes for the future of healthcare
-
In this bonus episode of the EMJ podcast, host Sue Saville, a medical correspondent, discusses the latest advancements in access and hemostasis for coronary and other procedures via the distal radial route. Joined by Pavan Najran, clinical lead for interventional radiology and Consultant Clinical and Interventional Radiologist, The Christie Hospital NHS Foundation Trust, Manchester, UK, they further explore the benefits of the distal radial method, emphasizing reduced vascular complications, improved patient comfort, and shorter haemostasis time. Najran highlights the ergonomic advantages, dispels misconceptions, and shares insights from trials and personal experience, showcasing the potential for distal radial access to become the preferred approach.
Pavan Najran, is a clinical lead for interventional radiology and Consultant Clinical and Interventional Radiologist, The Christie Hospital NHS Foundation Trust, Manchester, UK.
The publication of this podcast was funded by Merit Medical. Dr Najran is a consultant to Merit Medicall.
The suggestions and other information, which may include both Merit and third-party products, are for the practitioner’s convenience and for general information purposes only. This information does not constitute medical or legal advice, nor is it meant to endorse or guarantee the suitability of any of the referenced products or methods for any specific patient or procedure. Before using, refer to the Instructions for Use (IFU) for indications, contraindications, warnings, precautions, and directions for use.
-
This podcast explores the fascinating world of artificial intelligence and advances on the horizon in oncology. Jonathan and Sofia Merajver, Michigan Medicine, Ann Arbor, USA, discuss vaccine hesitancy, the promise of artificial intelligence in generating large datasets, and non-small cell lung cancer, before concluding with her three wishes for healthcare.
Use the following tiestamps tot navigate the episode!
(00:00)-Introduction
(00:46)-Breast cancer vaccine hesitancy
(07:38)-Advances on the horizon to prevent, protect, and treat malignancies
(09:30)-Hospitals in areas of conflict
(12:20)-Artificial intelligence
(17:28)-Non-small cell lung cancer
(23:10)-Sofia’s three wishes for healthcare
-
This podcast explores the genetic determinants and mechanisms of breast and ovarian cancer. Jonathan and Sofia Merajver, Michigan Medicine, Ann Arbor, USA, discuss brain metastases, the severity of inflammatory breast cancer, and the movement of cancers through tissue.
Use the following timestamps to navigate this episode!
(00:00)-Introduction
(02:27)-Sofia’s journey into medicine
(04:10)-Personal stakes
(05:09)-Not being your doctor
(06:58)-Genes in inflammatory breast cancer
(10:58)-RHO proteins
(12:52)-Brain metastasis
(17:33)-Crossing the blood–brain barrier
(22:11)-Aggressive phenotypes of breast cancer
(24:18)-Chemoprevention in breast cancer
-
This podcast explores the mOm Incubator, the importance of collaboration with healthcare professionals when designing medical devices, and the environmental impact of healthcare. Jonathan is joined by James Roberts, co-founder and CEO of mOm Incubators Ltd., a MedTech start-up on a mission to provide global access to high-quality healthcare. The pair discuss how the mOm incubator compares to traditional incubators, and the problems it solves.
Use the following timestamps to navigate this episode!
(00:00)-Introduction
(02:11)-Sparking interest in medical innovation
(04:11)-Navigating a medical device start-up
(07:03)-Unveiling the mOm incubator
(10:19)-The value of input from HCPs in device development
(13:04)-Delivering a simple yet low-risk device
(16:14)-Supplying mOm incubators to Ukraine
(20:16)-Considering the environmental impacts of medical devices
(23:30)-James’ proudest achievements
(26:58)-Looking to the future
(28:48)-Transport for London’s map of engineering icons
(31:09)-Three wishes for the future of healthcare
-
In this bonus episode of the EMJ podcast, Dr. Douglas Bradley is joining our host Dr Hannah Moir to discuss the recent outcomes from the ADVENT-HF randomised clinical trial. The discussion revolves around the relationship between heart failure and co-existing obstructive and/or central sleep apnoea. Dr Bradley considers the use of adaptive servo-ventilation (ASV), a non-invasive positive airway therapy, and provides insights on the trial outcomes. He also delves into the mechanism of action underlying ASV and discusses future developments in the sleep and cardiovascular space. This podcast has been funded by Philips.
-
In this final episode of the series, the discussion focuses on the role of therapeutic drug monitoring and current practices, as well as how treatment decisions are made for patients refractory to anti-TNFs. The guests conclude by discussing the future of anti-TNFs and identifying the remaining gaps in the care of patients with inflammatory bowel disease.
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
-
In this penultimate episode of the series on anti-TNFs for inflammatory bowel disease, our expert gastroenterologists discuss treatment options for difficult-to-treat Crohn’s disease and ulcerative colitis, including recent views and decision-making.
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
- Laat meer zien